Keiji Aoshima

608 total citations
25 papers, 451 citations indexed

About

Keiji Aoshima is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Keiji Aoshima has authored 25 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 10 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Keiji Aoshima's work include Blood Coagulation and Thrombosis Mechanisms (20 papers), Blood properties and coagulation (10 papers) and Protease and Inhibitor Mechanisms (5 papers). Keiji Aoshima is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (20 papers), Blood properties and coagulation (10 papers) and Protease and Inhibitor Mechanisms (5 papers). Keiji Aoshima collaborates with scholars based in Japan, United Kingdom and United States. Keiji Aoshima's co-authors include Eriko Morishita, Hidesaku Asakura, Masanori Saito, Ichiro Kumabashiri, Hiroshi Jokaji, Chika Uotani, Masahide Yamazaki, Tomoe Mizutani, Yasuo Ontachi and Tamotsu Matsuda and has published in prestigious journals such as Blood, Critical Care Medicine and Atherosclerosis.

In The Last Decade

Keiji Aoshima

24 papers receiving 409 citations

Peers

Countries citing papers authored by Keiji Aoshima

Since Specialization

Citations

This map shows the geographic impact of Keiji Aoshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiji Aoshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiji Aoshima more than expected).

Fields of papers citing papers by Keiji Aoshima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiji Aoshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiji Aoshima. The network helps show where Keiji Aoshima may publish in the future.

Co-authorship network of co-authors of Keiji Aoshima

This figure shows the co-authorship network connecting the top 25 collaborators of Keiji Aoshima. A scholar is included among the top collaborators of Keiji Aoshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiji Aoshima. Keiji Aoshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Marked difference in pathophysiology between tissue factor- and lipopolysaccharide-induced disseminated intravascular coagulation models in rats 2002 ·Critical Care Medicine ·Hidesaku Asakura, Yukio Suga, Keiji Aoshima, Yasuo Ontachi, Tomoe Mizutani, Minori Kato, Masanori Saito, Eriko Morishita, Masahide Yamazaki, Akiyoshi Takami, Ken‐ichi Miyamoto, Shinji Nakao	34
2	Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models 2002 ·Blood Coagulation & Fibrinolysis ·Hidesaku Asakura, (unknown), (unknown), (unknown), Yasuo Ontachi, Tomoe Mizutani, Minori Kato, Takamichi Ito, Hiroshi Yamazaki, Keiji Aoshima, Eriko Morishita, Mikako Saito, Ken‐ichi Miyamoto, Shinji Nakao	6
3	Decreased plasma activity of antithrombin or protein C is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation 2001 ·European Journal Of Haematology ·Hidesaku Asakura, Yasuo Ontachi, Tomoe Mizutani, Minori Kato, Takako Ito, Masanori Saito, Eriko Morishita, Masahide Yamazaki, Keiji Aoshima, Akiyoshi Takami, Tomotaka Yoshida, Yukio Suga, Ken‐ichi Miyamoto, Shinji Nakao	49
4	All-trans retinoic acid is partially effective against lipopolysaccharide-induced but not against tissue-factor-induced disseminated intravascular coagulation in rat models 2001 ·Blood Coagulation & Fibrinolysis ·Hidesaku Asakura, Keiji Aoshima, (unknown), (unknown), (unknown), Eriko Morishita, (unknown), Yasuo Ontachi, (unknown), Minori Kato, Ken‐ichi Miyamoto, Shinji Nakao	8
5	An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation 2001 ·Critical Care Medicine ·Hidesaku Asakura, Yasuo Ontachi, Tomoe Mizutani, Minori Kato, Masanori Saito, Ichiro Kumabashiri, Eriko Morishita, (unknown), Keiji Aoshima, Shinji Nakao	63
6	Prednisolone inhibits endotoxin-induced disseminated intravascular coagulation and improves mortality in rats 1999 ·Blood Coagulation & Fibrinolysis ·(unknown), Keiji Aoshima, Tomoe Mizutani, Yasuo Ontachi, Mikako Saito, Eriko Morishita, Hidesaku Asakura, T Matsuda, Douglas A. Triplett	14
7	Differences in Pathophysiology between TF and LPS-induced Rat DIC Model. 1999 ·Japanese Journal of Thrombosis and Hemostasis ·(unknown), Hidesaku Asakura, Keiji Aoshima, Masahide Yamazaki, Yukio Suga, (unknown), Eriko Morishita, Masanori Saito, Yasuo Ontachi, Tomoe Mizutani, (unknown), Ken‐ichi Miyamoto, Tamotsu Matsuda	6
8	[An approach to the problems posed by diagnostic criteria for disseminated intravascular coagulation]. 1999 ·PubMed ·(unknown), Keiji Aoshima	0
9	Treatment of Disseminated Intravascular Coagulation (DIC) with All-transRetinoic Acid in an Endotoxin-Induced Rat Model 1998 ·Seminars in Thrombosis and Hemostasis ·Keiji Aoshima, Hidesaku Asakura, (unknown), (unknown), Ichiro Kumabashiri, Eriko Morishita, Yasuo Ontachi, Tomoe Mizutani, (unknown), (unknown)	13
10	Prothrombin Fragment 1+2 Measures Treatment Effect in Patients with Antiphospholipid Syndrome 1998 ·Thrombosis Research ·Masahide Yamazaki, Hidesaku Asakura, Masanori Saito, Hiroshi Jokaji, Chika Uotani, Ichiro Kumabashiri, Eriko Morishita, Keiji Aoshima, Tamotsu Matsuda, Douglas A. Triplett	4
11	Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus 1996 ·Atherosclerosis ·Eriko Morishita, Hidesaku Asakura, Hiroshi Jokaji, Masanori Saito, Chika Uotani, Ichiro Kumabashiri, Masahide Yamazaki, Keiji Aoshima, Takuma Hashimoto, Tamotsu Matsuda	49
12	Hypercoagulability and high lipoprotein(a) levels in patients with aplastic anemia receiving cyclosporine 1996 ·Blood Coagulation & Fibrinolysis ·Eriko Morishita, Shinji Nakao, Hiroshi Asakura, Hiroshi Jokaji, Masanori Saito, Chika Uotani, Ichiro Kumabashiri, (unknown), Takashi Yoshida, Kenichi Takemoto, Keiji Aoshima, Takuma Hashimoto, Tomoki Matsuda	7
13	Protective Effects of DX-9065a, an Orally Active, Novel Synthesized and Selective Inhibitor of Factor Xa, Against Thromboplastin-Induced Experimental Disseminated Intravascular Coagulation in Rats 1996 ·Seminars in Thrombosis and Hemostasis ·Masahide Yamazaki, Hidesaku Asakura, Keiji Aoshima, Masanori Saito, Hiroshi Jokaji, Chika Uotani, Ichiro Kumabashiri, Eriko Morishita, Takayuki Ikeda, Tamotsu Matsuda	20
14	Mechanism of Activation of Coagulation Induced by Tissue-Type Plasminogen activator : Studies by Using Coagulation Factor Deficient Plasma 1995 ·Masanori Saito, Hidesaku Asakura, Hiroshi Jokaji, Chika Uotani, Ichiro Kumabashiri, Eriko Morishita, (unknown), Keiji Aoshima, Tamotsu Matsuda	2
15	Haemostatic and fibrinolytic parameters in septic patients with leukopenia or leukocytosis 1995 ·European Journal Of Haematology ·Masanori Saito, Hidesaku Asakura, Hiroshi Jokaji, Chika Uotani, Ichiro Kumabashiri, Eriko Morishita, Masahide Yamazaki, Tomotaka Yoshida, Keiji Aoshima, Tamotsu Matsuda	3
16	Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy 1995 ·Blood Coagulation & Fibrinolysis ·Mikako Saito, Hiroshi Asakura, Hiroshi Jokaji, Chika Uotani, Ichiro Kumabashiri, Eriko Morishita, Hiroshi Yamazaki, Keiji Aoshima, T Matsuda	21
17	Relationship between elevation in the plasma concentration of elastase-??1 proteinase inhibitor complex (E-??1PI) and haemostatic parameters during haemodialysis 1995 ·Blood Coagulation & Fibrinolysis ·Hiroshi Yamazaki, Hiroshi Asakura, Mikako Saito, Hiroshi Jokaji, Chika Uotani, Ichiro Kumabashiri, Eriko Morishita, Keiji Aoshima, Takahiro Sato, (unknown), (unknown), Yusuke Kawamura, Takio Ohka, Takayuki Ikeda, Tomokazu Matsuda	3
18	Levels of activated factor VII in patients with disseminated intravascular coagulation [letter] 1995 ·Blood ·(unknown), Hiroshi Asakura, Toshimi Yoshida, Hiroshi Jokaji, Chika Uotani, Ichiro Kumabashiri, Eriko Morishita, (unknown), Keiji Aoshima, T Matsuda	1
19	Mechanism of Activation of Coagulation Induced by Tissue-Type Plasminogen activator 1995 ·Japanese Journal of Thrombosis and Hemostasis ·Masanori Saito, Hidesaku Asakura, Hiroshi Jokaji, Chika Uotani, Ichiro Kumabashiri, Eriko Morishita, (unknown), Keiji Aoshima, Tamotsu Matsuda	2
20	Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers 1994 ·Blood Coagulation & Fibrinolysis ·Hidesaku Asakura, Hiroshi Jokaji, Mikako Saito, Chika Uotani, Ichiro Kumabashiri, Eriko Morishita, Hiroshi Yamazaki, Keiji Aoshima, T Matsuda	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact